China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015)
China Pharma Holdings' (CPHI) quarterly Income from Non-Controlling Interests came in at $1.4 million in Q2 2015, up 116.33% YoY from $640928.2 in Q2 2014, and up 116.33% on a QoQ basis from -$8.5 million in Q2 2014.
China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015) Analysis & Trends
China Pharma Holdings (CPHI) has 4 years of Income from Non-Controlling Interests data on file, last reported at $1.4 million in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.43 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.39 Mn |
| Jun 30, 2014 | -8.49 Mn |
| Sep 30, 2013 | -1.42 Mn |
| Sep 30, 2012 | 1.17 Mn |